clotrimazole has been researched along with Carcinoma, Ehrlich Tumor in 1 studies
Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
Excerpt | Relevance | Reference |
---|---|---|
"Clotrimazole was the most potent antiangiogenic compound and the agent capable of inhibiting tumor growth." | 1.32 | Differential effects of antiangiogenic compounds in neovascularization, leukocyte recruitment, VEGF production, and tumor growth in mice. ( Andrade, SP; Barcelos, LS; Belo, AV; Ferreira, MA; Teixeira, MM, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belo, AV | 1 |
Barcelos, LS | 1 |
Teixeira, MM | 1 |
Ferreira, MA | 1 |
Andrade, SP | 1 |
1 other study available for clotrimazole and Carcinoma, Ehrlich Tumor
Article | Year |
---|---|
Differential effects of antiangiogenic compounds in neovascularization, leukocyte recruitment, VEGF production, and tumor growth in mice.
Topics: Acetylglucosaminidase; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Carcinoma, Ehrlic | 2004 |